newsfilter
← Latest News
Business Wire·

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

HeartBeam Enters New Growth Phase Following FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment First Commercial Partner ClearCardio™ to Bring HeartBeam's 3D ECG